全文获取类型
收费全文 | 42203篇 |
免费 | 3380篇 |
国内免费 | 2502篇 |
出版年
2024年 | 47篇 |
2023年 | 446篇 |
2022年 | 1175篇 |
2021年 | 2034篇 |
2020年 | 1261篇 |
2019年 | 1559篇 |
2018年 | 1441篇 |
2017年 | 1116篇 |
2016年 | 1651篇 |
2015年 | 2462篇 |
2014年 | 2884篇 |
2013年 | 3118篇 |
2012年 | 3634篇 |
2011年 | 3435篇 |
2010年 | 1966篇 |
2009年 | 1818篇 |
2008年 | 2099篇 |
2007年 | 1877篇 |
2006年 | 1621篇 |
2005年 | 1426篇 |
2004年 | 1206篇 |
2003年 | 1059篇 |
2002年 | 910篇 |
2001年 | 851篇 |
2000年 | 741篇 |
1999年 | 717篇 |
1998年 | 439篇 |
1997年 | 464篇 |
1996年 | 442篇 |
1995年 | 392篇 |
1994年 | 381篇 |
1993年 | 309篇 |
1992年 | 441篇 |
1991年 | 385篇 |
1990年 | 331篇 |
1989年 | 246篇 |
1988年 | 236篇 |
1987年 | 198篇 |
1986年 | 141篇 |
1985年 | 185篇 |
1984年 | 121篇 |
1983年 | 105篇 |
1982年 | 80篇 |
1981年 | 60篇 |
1980年 | 55篇 |
1979年 | 72篇 |
1978年 | 66篇 |
1977年 | 46篇 |
1976年 | 48篇 |
1973年 | 48篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
971.
972.
973.
Wang Che Huang Lili Li Ruojin Wang Ying Wu Xiaoxue Shang Dejing 《International journal of peptide research and therapeutics》2021,27(4):2291-2301
International Journal of Peptide Research and Therapeutics - Multidrug resistance (MDR) is one of the major obstacles to efficient chemotherapy against cancers, resulting from the overexpression of... 相似文献
974.
Wu Shaozhen He Zhiping Wang Qingqing Wu Fenghua Liu Xingquan 《International journal of peptide research and therapeutics》2021,27(2):1239-1251
International Journal of Peptide Research and Therapeutics - Pecan cake, a by-product of pecan processing, has not been fully developed and utilized. It contains proteins with high nutritional... 相似文献
975.
Hong-Wei Zhang Yi Shi Ji-Bin Liu Hui-Min Wang Pei-Yao Wang Zhi-Jun Wu Liu Li Li-Peng Gu Ping-Sheng Cao Gao-Ren Wang Yu-Shui Ma Da Fu 《Journal of cellular and molecular medicine》2021,25(8):3699-3713
MicroRNA-24-3p (miR-24-3p) has been implicated as a key promoter of chemotherapy resistance in numerous cancers. Meanwhile, cancer-associated fibroblasts (CAFs) can secret exosomes to transfer miRNAs, which mediate tumour development. However, little is known regarding the molecular mechanism of CAF-derived exosomal miR-24-3p in colon cancer (CC). Hence, this study intended to characterize the functional relevance of CAF-derived exosomal miR-24-3p in CC cell resistance to methotrexate (MTX). We identified differentially expressed HEPH, CDX2 and miR-24-3p in CC through bioinformatics analyses, and validated their expression in CC tissues and cells. The relationship among HEPH, CDX2 and miR-24-3p was verified using ChIP and dual-luciferase reporter gene assays. Exosomes were isolated from miR-24-3p inhibitor–treated CAFs (CAFs-exo/miR-24-3p inhibitor), which were used in combination with gain-of-function and loss-of-function experiments and MTX treatment. CCK-8, flow cytometry and colony formation assays were conducted to determine cell viability, apoptosis and colony formation, respectively. Based on the findings, CC tissues and cells presented with high expression of miR-24-3p and low expression of HEPH and CDX2. CDX2 was a target gene of miR-24-3p and could up-regulate HEPH. Under MTX treatment, overexpressed CDX2 or HEPH and down-regulated miR-24-3p reduced cell viability and colony formation and elevated cell apoptosis. Furthermore, miR-24-3p was transferred into CC cells via CAF-derived exosomes. CAF-derived exosomal miR-24-3p inhibitor diminished cell viability and colony formation and increased cell apoptosis in vitro and inhibited tumour growth in vivo under MTX treatment. Altogether, CAF-derived exosomal miR-24-3p accelerated resistance of CC cells to MTX by down-regulating CDX2/HEPH axis. 相似文献
976.
Mengtian Fan Jinghong Wu Xian Li Yingjiu Jiang Xiaowen Wang Mengjun Bie Yaguang Weng Sicheng Chen Bin Chen Liqin An Menghao Zhang Gaigai Huang Mengying Zhu Qiong Shi 《Journal of cellular and molecular medicine》2021,25(1):132-146
It has been reported that chemokine CX3CL1 can regulate various tumours by binding to its unique receptor CX3CR1. However, the effect of CX3CL1-CX3CR1 on the lung adenocarcinoma and lung squamous cell carcinoma is still unclear. Here, we showed that CX3CL1 can further invasion and migration of lung adenocarcinoma A549 and lung squamous cell carcinoma H520. In addition, Western blot and immunofluorescence test indicated CX3CL1 up-regulated the phosphorylation level of cortactin, which is a marker of cell pseudopodium. Meanwhile, the phosphorylation levels of c-Src and c-Abl, which are closely related to the regulation of cortactin phosphorylation, are elevated. Nevertheless, the src/abl inhibitor bosutinib and mutations of cortactin phosphorylation site could inhibit the promotion effect of CX3CL1 on invasion and migration of A549 and H520. Moreover, these results of MTT, Hoechst staining and Western blot suggested that CX3CL1 had no effect on the proliferation and apoptosis of A549 and H520 in vitro. The effects of CX3CL1 were also verified by the subcutaneous tumour formation in nude mice, which showed that it could promote proliferation and invasion of A549 in vivo. In summary, our results indicated that CX3CL1 furthered invasion and migration in lung cancer cells partly via activating cortactin, and CX3CL1 may be a potential molecule in regulating the migration and invasion of lung cancer. 相似文献
977.
Huaji Jiang Jialiang Zhong Wenjun Li Jianghui Dong Cory J Xian Yung-Kang Shen Lufeng Yao Qiang Wu Liping Wang 《Journal of cellular and molecular medicine》2021,25(23):10825-10836
Osteoporosis is characterized by increased bone fragility, and the drugs used at present to treat osteoporosis can cause adverse reactions. Gentiopicroside (GEN), a class of natural compounds with numerous biological activities such as anti-resorptive properties and protective effects against bone loss. Therefore, the aim of this work was to explore the effect of GEN on bone mesenchymal stem cells (BMSCs) osteogenesis for a potential osteoporosis therapy. In vitro, BMSCs were exposed to GEN at different doses for 2 weeks, whereas in vivo, ovariectomized osteoporosis was established in mice and the therapeutic effect of GEN was evaluated for 3 months. Our results in vitro showed that GEN promoted the activity of alkaline phosphatase, increased the calcified nodules in BMSCs and up-regulated the osteogenic factors (Runx2, OSX, OCN, OPN and BMP2). In vivo, GEN promoted the expression of Runx2, OCN and BMP2, increased the level of osteogenic parameters, and accelerated the osteogenesis of BMSCs by activating the BMP pathway and Wnt/β-catenin pathway, effect that was inhibited using the BMP inhibitor Noggin and Wnt/β-catenin inhibitor DKK1. Silencing the β-catenin gene and BMP2 gene blocked the osteogenic differentiation induced by GEN in BMSCs. This block was also observed when only β-catenin was silenced, although the knockout of BMP2 did not affect β-catenin expression induced by GEN. Therefore, GEN promotes BMSC osteogenesis by regulating β-catenin-BMP signalling, providing a novel strategy in the treatment of osteoporosis. 相似文献
978.
979.
Ning Xie Yunfan Bai Lu Qiao Yuru Bai Jian Wu Yan Li Mingzuo Jiang Bing Xu Zhen Ni Ting Yuan Yongquan Shi Kaichun Wu Feng Xu Jinhai Wang Lei Dong Na Liu 《Journal of cellular and molecular medicine》2021,25(8):4014-4027
The ADP-ribosylation factor-like proteins (ARLs) have been proved to regulate the malignant phenotypes of several cancers. However, the exact role of ARLs in gastric cancer (GC) remains elusive. In this study, we systematically investigate the expression status, interactive relations, potential pathways, genetic variations and clinical values of ARLs in GC. We find that ARLs are significantly dysregulated in GC and involved in various cancer-related pathways. Subsequently, machine learning models identify ARL4C as one of the two most significant clinical indicators among ARLs for GC. Furthermore, ARL4C silencing remarkably inhibits the growth and metastasis of GC cells both in vitro and in vivo. Moreover, enrichment analysis indicates that ARL4C is highly correlated with TGF-β1 signalling. Correspondingly, TGF-β1 treatment dramatically increases ARL4C expression and ARL4C knockdown inhibits the phosphorylation level of Smads, downstream factors of TGF-β1. Meanwhile, the coexpression of ARL4C and TGF-β1 worsens the prognosis of GC patients. Our work comprehensively demonstrates the crucial role of ARLs in the carcinogenesis of GC and the specific mechanisms underlying the GC-promoting effects of TGF-β1. More importantly, we uncover the great promise of ARL4C-targeted therapy in improving the efficacy of TGF-β1 inhibitors for GC patients. 相似文献
980.
Yu-Shui Ma Ting-Miao Wu Bin Qian Yu-Shan Liu Hua Ding Ming-Ming Fan Ji-Bin Liu Fei Yu Hui-Min Wang Yi Shi Li-Peng Gu Liu Li Lin-Lin Tian Pei-Yao Wang Gao-Ren Wang Zhi-Jun Wu Qi-Fei Zou Chang-Chun Ling Da Fu 《Journal of cellular and molecular medicine》2021,25(8):4040-4052
Hepatocellular cancer (HCC) has been reported to belong to one of the highly vascularized solid tumours accompanied with angiogenesis of human umbilical vein endothelial cells (HUVECs). KDM5A, an attractive drug target, plays a critical role in diverse physiological processes. Thus, this study aims to investigate its role in angiogenesis and underlying mechanisms in HCC. ChIP-qPCR was utilized to validate enrichment of H3K4me3 and KDM5A on the promotor region of miR-433, while dual luciferase assay was carried out to confirm the targeting relationship between miR-433 and FXYD3. Scratch assay, transwell assay, Edu assay, pseudo-tube formation assay and mice with xenografted tumours were conducted to investigate the physiological function of KDM5A-miR-433-FXYD3-PI3K-AKT axis in the progression of HCC after loss- and gain-function assays. KDM5A p-p85 and p-AKT were highly expressed but miR-433 was down-regulated in HCC tissues and cell lines. Depletion of KDM5A led to reduced migrative, invasive and proliferative capacities in HCC cells, including growth and a lowered HUVEC angiogenic capacity in vitro. Furthermore, KDM5A suppressed the expression of miR-433 by demethylating H3K4me3 on its promoterregion. miR-433 negatively targeted FXYD3. Depleting miR-433 or re-expressing FXYD3 restores the reduced migrative, invasive and proliferative capacities, and lowers the HUVEC angiogenic capacity caused by silencing KDM5A. Therefore, KDM5A silencing significantly suppresses HCC tumorigenesis in vivo, accompanied with down-regulated miR-433 and up-regulated FXYD3-PI3K-AKT axis in tumour tissues. Lastly, KDM5A activates the FXYD3-PI3K-AKT axis to enhance angiogenesis in HCC by suppressing miR-433. 相似文献